Phase 3 data showed lower rates of nausea and vomiting compared to GLP-1 therapiespotentially better tolerated for some patients
Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease
Different medications are indicated for different treatments, speak to your doctor to find out more about what works best for you
Even among other doctors, I still frequently hear, If only the patient would eat less or exercise more. Of course, this outdated thinking is not the case at all, Dr
207 In the entorhinal cortex and hippocampus of AD patients, high-molecular-weight DNA fragmentation and altered nuclear morphology suggest increased apoptosis
251 The results of immunoblotting and immunocytochemistry of central nervous system tissues suggested elevated p53 protein levels and the abnormal localization of p53 in ALS patients